SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001485003-15-000005
Filing Date
2015-08-13
Accepted
2015-08-13 16:37:09
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ebio-063015x10q.htm 10-Q 955104
2 EXHIBIT 31.1 ebio-063015x311.htm EX-31.1 12038
3 EXHIBIT 31.2 ebio-063015x312.htm EX-31.2 11904
4 EXHIBIT 32.1 ebio-063015x321.htm EX-32.1 6949
11 acphase3a01.jpg GRAPHIC 44966
  Complete submission text file 0001485003-15-000005.txt   3502244

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ebio-20150630.xml EX-101.INS 571514
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ebio-20150630.xsd EX-101.SCH 24608
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ebio-20150630_cal.xml EX-101.CAL 39906
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ebio-20150630_def.xml EX-101.DEF 88995
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ebio-20150630_lab.xml EX-101.LAB 351838
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ebio-20150630_pre.xml EX-101.PRE 197092
Mailing Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142 617-871-9911
Eleven Biotherapeutics, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 252025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36296 | Film No.: 151051187
SIC: 2834 Pharmaceutical Preparations